| Literature DB >> 35807193 |
Pratima Panda1, Lora Mishra1, Shashirekha Govind1, Saurav Panda2, Barbara Lapinska3.
Abstract
This systematic review aimed to evaluate interventions individually and compare the clinical outcome of young, immature teeth treated with regenerative endodontic therapy (RET) and apexification procedure. The protocol was registered with PROSPERO (International Prospective Register of Systematic Reviews), bearing the registration number CRD42021230284. A bibliographic search in the biomedical databases was conducted in four databases-PubMed, CENTRAL, EMBASE and ProQuest-using searching keywords and was limited to studies published between January 2000 and April 2022 in English. The search was supplemented by manual searching, citation screening and scanning of all reference lists of selected paper. The study selection criteria were randomized clinical trial, prospective clinical studies and observational studies. The search found 32 eligible articles, which were included in the study. The quality assessment of the studies was performed using the Cochrane risk of bias tool for randomized control trials and non-randomized clinical studies. The meta-analysis was performed using Review Manager software (REVMAN, version 5). The results indicated that a clinicians' MTA apexification procedure was more successful compared to calcium hydroxide. In RET, apical closure and overall success rate is statistically same for both apical platelet concentrates (APCs) and blood clots (BC). Both interventions have similar survival rates; however, RET should be preferred in cases where the root development is severely deficient, there is insufficient dentine and the tooth's prognosis is hopeless even with an apexification procedure.Entities:
Keywords: apexification; endodontic therapy; immature permanent tooth; pulp; regeneration
Year: 2022 PMID: 35807193 PMCID: PMC9267570 DOI: 10.3390/jcm11133909
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.964
Search strategy.
| Search Strategy |
|---|
| #1 immature teeth/immature tooth/immature permanent tooth/immature permanent teeth/young permanent tooth/young permanent dentition |
| #2 pulp revascularization/pulp regeneration/pulp revitalization/PRF/PRP/blood clot |
| #3 apexification/calcific barrier/apical closure/root end closure/root apex closure/root end formation/root apex closure/apical plug/MTA plug |
| #4 survival rate/dentinal thickness/pulp vitality/root completion/successful rate/periapical healing/decrease in apical foramen width |
Inclusion and exclusion criteria for selecting studies in the systematic review.
| Inclusion Criteria | Exclusion Criteria |
|---|---|
| Study design: Randomized controlled trials, clinical studies, observational studies (Retrospective study) | Case reports, comments, conference proceedings |
| Patients with immature necrotic permanent teeth | Studies experimenting on vital teeth |
| Studies in which either one of the interventions or both are compared | Animal studies, case reports, in vitro studies, laboratory studies |
| Articles published in English language |
Figure 1PRISMA 2020 flow diagram for systematic review that includes searches of databases.
List of excluded studies after reading the full text.
| Study | Reason for Exclusion |
|---|---|
| Alhaddad Alhamoui et al., 2014 [ | In vitro study |
| Alkaisi et al., 2013 [ | Animal study |
| El Arshy et al., 2016 [ | Animal study |
| El-Tayeb et al., 2019 [ | Animal study |
| Huang et al., 2013 [ | Animal study |
| Peng et al., 2017 [ | Chinese language |
| Jamshidi et al., 2018 [ | In vitro study |
| Moradi et al., 2016 [ | Animal study |
| Ok et al., 2015 [ | In vitro study |
| Pagliarin et al., 2016 [ | Animal study |
| Rafaei et al., 2020 [ | In vitro study |
| Ritter AL et al., 2004 [ | Animal study |
| Sogukpinar et al., 2020 [ | In vitro study |
| Thibodeau et al., 2007 [ | In vitro study |
| Valera et al., 2015 [ | Animal study |
| Yang et al., 2018 [ | Animal study |
| Yoo et al., 2014 [ | Animal study |
| Zhang et al., 2014 [ | Animal study |
| Zuong et al., 2010 [ | Animal study |
| Beslot-Neveu et al., 2011 [ | Study protocol |
| Bukhari et al., 2016 [ | Case series |
Data extraction from included studies – the clinical protocol.
| Author | Etiology of Pulp Necrosis | Presence of Periapical Lesion | Instrumentation | Irrigation | Intracanal | Recall Time (in Weeks) | Preparation Protocol of APC | Access Restoration |
|---|---|---|---|---|---|---|---|---|
| Alagl et al., 2017 [ | Secondary to trauma/caries | Yes | No | 2.5% NaOCl (20 mL), sterile saline (20 mL), and 0.12% CHX (10 mL), followed by 17% EDTA after 3 weeks | TAP | 3 | PRP was prepared according to the description by Dohan et al. [ | NR |
| Bezgin et al., 2015 [ | Secondary to trauma/caries | Yes | No | 2.5% NaOCl (20 mL), sterile saline (20 mL), and 0.12% CHX (10 mL), followed by 5% EDTA (20 mL) after 3 weeks | TAP | 3 | PRP was prepared according to the description by Dohan et al. [ | Final restoration was completed with white MTA (Angelus, Londrina, Brazil), reinforced GI cement (Ketac Molar Easymix; 3M ESPE, Seefeld, Germany) and composite resin (Filtek Supreme XT; 3M ESPE, St Paul, MN, USA) |
| Elsheshtawy et al., 2020 [ | Secondary to trauma and Dens invaginatus | Yes | No | 20 mL of 5.25% NaOCl. At recall, 20 mL of 2.5% NaOCl, followed by 20 mL sterile saline and 10 mL of 17% EDTA solution | TAP | NR | PRP was prepared according to Dohan et al. [ | MTA, using a layer of reinforced GI (Riva self-cure, SDI limited, Bayswater, Victoria, Australia), followed by resin composite (Filtek Z250 universal restorative, 3 mol L, 3M ESPE, St. Paul, MN, USA) |
| Jadhav et al., 2012 [ | Secondary to trauma/caries | No | Minimal (#60H file) | 2.5% NaOCl (copious irrigation) | TAP | NR | PRP: 8 mL of blood drawn by venipuncture of the antecubital vein was collected in a 10 mL sterile glass tube coated with an anticoagulant (acid citrate dextrose) and centrifuged at 2400 rpm for 10 min to separate PRP and platelet-poor plasma (PPP) from the red blood cell fraction. The topmost layer (PRP + PPP) was transferred to another tube and again centrifuged at 3600 rpm for 15 min to separate the PRP to precipitate at the bottom of the glass tube. This was mixed with 1 mL 10% calcium chloride to activate the platelets and to neutralize the acidity of acid citrate dextrose. | Resin-modified GI cement (Photac-Fill; 3M ESPE, St Paul, MN, USA) |
| Rizk et al., 2019 [ | Secondary to trauma | Yes | No | 20 mL 2% NaOCl for 5 min, followed by 20 mL 17% EDTA. | TAP | 3 | PRP was prepared according to the description by Dohan et al. [ | An MTA orifice plug extending 2–3 mm in the canal was used to seal the canal orifice then GI (GC America, Alsip, IL, USA) and composite (Z250, 3M ESPE) were applied to give an effective and durable seal |
| Ragab et al., 2019 [ | Secondary to trauma | Yes | No | 20 mL of 5.25% NaOCl followed by 20 mL sterile saline. | DAP | 3 | PRF was prepared by drawing 12 mL sample of whole blood intravenously from the patient’s right antecubital vein and centrifuged at 3000 rpm for 12 min. | MTA plus Light Cure GI cement |
| Mittal et al., 2019 [ | Secondary to trauma/caries | Yes | Minimal (#30k file) | 2.5% NaOCl (copious irrigation). | DAP | 4 | PRF was prepared by drawing 5 mL of venous blood from the patient, collected in a dried glass test tube, and centrifuged at 2700 rpm for 12 min. | GI cement followed by composite resin |
| Shivashankar et al., 2017 [ | Secondary to trauma/caries | No | Minimal | 5.25% NaOCl (copious irrigation). | TAP | 3 | NR | NR |
| Hazim Rizk et al., 2020 [ | Trauma, Caries | Yes | No | 20 mL of 2.5% NaOCl followed by 20 mL of 17% EDTA. At recall 20 mL sterile saline followed by 20 mL 17% EDTA solution | TAP | 3 | PRP and PRF was prepared according to Dohan and Choukroun (2007) [ | MTA, using a layer of GI (GC America, Alsip, IL, USA) followed by composite (Z 250, 3 M ESPE) |
| Jiang et al., 2017 [ | Trauma, Broken central cusp | Yes | NO | 20 mL 1.25% NaOCl. At recall, 20 mL 17% EDTA. | Ca(OH)2 paste | 2 | NR | A layer of Filtek Z250 composite resin (3M ESPE, Irvine, CA; 3–4 mm) was placed over the capping material for the final restoration. |
| Narang et al., 2015 [ | Secondary to trauma/caries | Yes | Minimal | 2.5% NaOCl (copious irrigation) | TAP | 4 | NR | Resin-modified GI cement was placed extending 3–4 mm in the canal. Access cavity was sealed with composite (Clearfil Majesty, Kuraray Medical Inc., Tokyo, Japan). |
| Meschi et al., 2021 [ | Trauma, Caries, Anatomic anomaly (dens invaginatus) | Yes | No | 20 mL 1.5% NaOCl and subsequently with 20 mL saline. At recall, 30 mL EDTA 17% 1 mm short of the working length. | DAP | 2 | Blood samples were centrifuged. Fibrin clots were collected after centrifugation, and 2 of them were transformed into membranes after 5 min of pressure under a sterile glass plate. | Tooth was sealed by means of a GI lining and composite restoration. |
| Ulusoy et al., 2019 [ | Secondary to trauma | Yes | No | 20 mL 1.25% NaOCl. At recall, 2% CHX, saline and 1 mL 17% EDTA. | TAP | 4 | PRP: Citrated blood was centrifuged in a standard laboratory centrifuge PK 130 (ALC International; ColognoMonzese, Italy) for 15 min at 1250 rpm to obtain PRP without erythrocytes and leukocytes. PRF: 10 mL blood was collected in a sterile tube without anticoagulant and centrifuged immediately for 10 min at a speed of 3000 rpm (Andreas Hettich Group, Ltd., Tuttlingen, Germany). | MTA coronal barrier was sealed with a thin GI base, and final coronal restorations were placed at the same visit using acid etch composite resin. |
| Jayadevan et al., 2021 [ | Trauma | No | Minimal (#80–120K file) | 1.5% NaOCl solution (20 mL) followed by saline and 17% EDTA. Recall session, copious and gentle irrigation with saline and 20 mL of 17% EDTA. | TAP | 4 | A-PRF or PRF was freshly prepared using a centrifuge (R-8C Laboratory centrifuge, Remi Lab, Mumbai, India). For PRF, 10 mL of intravenous blood was drawn into a tube without anticoagulant and centrifuged at 2700 rpm for 12 min. For A-PRF, 10 mL of intravenous blood was drawn into a tube without anticoagulant and centrifuged at 1500 rpm for 14 min. | GI cement (GC, Fuji IX, GC India) was placed gently in a thickness of about 3–4 mm over the Biodentine and the access was temporized with Cavit. Post regenerative treatment consisted of non-vital bleaching or composite restoration. These procedures were performed after a period of one week. |
| Peng et al., 2017 [ | Anatomic, Caries, Trauma | Yes | Minimal (#30K file) | 5.25% NaOCl solution (20 mL) | TAP | 1–4 | NR | Conventional GI cement (Fuji IX, Fuji Corporation, Osaka, Japan) was placed over the blood clot at the level of CEJ, followed by phosphoric acid etching for 30 s, a single-bond adhesive agent, and placement of Filtek Z250 composite resin (3M ESPE, Irvine, CA, USA). Instead of GI cement, mixture of ProRoot MTA (Dentsply Tulsa Dental, Johnson |
| Lv et al., 2018 [ | Dens evaginatus, Tooth fracture | Yes | Minimal (35 K-file) | 20 mL of 1% NaOCl followed by 10 mL of 17% EDTA solution | TAP | 4 | PRF was prepared as described by Choukroun et al. [ | A 3-mm-thick layer of MTA was placed followed by a moist cotton pellet and Cavit. One week later, the Cavit was removed and replaced with a bonded resin restoration (Filtek Z350 XT: 3M ESPE Dental Products, St Paul, MN, USA). |
| Cheng et al., 2022 [ | Secondary to trauma | No | Minimal or No | 0.5–1.5% NaOCl and saline or NaOCl in combination with saline and 17% EDTA | TAP | 2 | CGF was prepared from the patient’s intravenous blood. After immediate differential centrifugation of blood, CGF was represented as the buffy coat in the middle layer. Then the CGF layer was separated using sterile scissors. | Teeth were restored with a bio-ceramic material [i.e., MTA (Dentsply Sirona, Ballaigues, Switzerland) or iRoot BP Plus (Innovative Bioceramix Inc, Vancouver, BC, Canada)] followed by various restorative materials. |
| Chueh et al., 2009 [ | Trauma | Yes | No | 2.5% NaOCl | Ca(OH)2 paste | 1–2 | NR | The access was sealed with temporary filling materials or resin. |
| Bonte et al., 2014 [ | Trauma | Yes | No | Active 3% NaOCl | - | - | - | Composite resin |
| Santhakumar et al., 2018 [ | Trauma and Dental caries | Yes | No | 3% NaOCl followed by saline | TAP | 3 | A 5 mL blood sample was taken from the patient’s anticubital vein. The blood was centrifuged without anticoagulant at 3000 rpm for 10 min, and PRF gel was obtained at the bottom of the test tube and was removed with a sterile tweezer. After obtaining PRF gel, it was squeezed using especially designed PRF compression device to remove the excess fluid. The membrane obtained was cut linearly in the shape of root canal space for ease of placement. | Triple sealed with MTA (ProRoot MTA), type II GI cement (Fugi 2) and composite material (3M ESPE). |
| Kandemir Demirci et al., 2019 [ | Trauma, Dens invaginatus, Caries | Yes | No | 2.5% NaOCl solution. At recall, 2.5% NaOCl, 17% EDTA followed by 2% CHX | Ca(OH)2 powder mixed with saline | 1 | - | Bonded composite resin |
| Tek et al. 2021 [ | Trauma | Yes | Yes | 2.5% NaOCl solution. Recall 2.5% NaOCl solution followed by distilled water | Ca(OH)2 paste | 1 | - | Resin composite (3M ESPE Filtek Ultimate Seefeld, Germany) |
| Kinirons et al., 2001 [ | Trauma | NR | No | NR | - | - | - | NR |
| Lin et al., 2017 [ | Secondary to trauma/Dens evaginatus | Yes | Minimal (#25 K file) | 20 mL 1.5% NaOCl, 0.9% physiological saline, 20 mL 17% EDTA | TAP | 3 | - | GI cement followed by composite resin |
| Xuan et al., 2018 [ | Secondary to trauma | Yes | No | NR | NR | 4 | The pulp tissue for hDPSC isolation was harvested using standard sterile techniques. Autologous hDPSCs were obtained from the patient’s maxillary deciduous canine tooth. | NR |
| Alobaid et al., 2014 [ | Secondary to Trauma | Yes | No | 20 mL 17% EDTA | TAP | 3 | PRP and PRF were prepared according to the method of Dohan and Choukroun (2007) [ | An MTA orifice plug extending 2–3 mm in the canal was used to seal the canal orifice then GI (GC America, Alsip, IL, USA) and composite (Z 250, 3 M ESPE) to give an effective and durable seal. |
| Casey et al., 2022 [ | Secondary to trauma | Yes | Minimal | Varying concentrations of NaOCl, CHX, and/or EDTA | TAP | 2 | NR | Resin bonded restoration |
| Caleza-Jimenez et al., 2022 [ | Trauma, Caries | Yes | No | 1.5–2.5% NaOCl and 17% EDTA | TAP | 2 | NR | Composite restoration |
| Pereira et al., 2021 [ | Trauma | No | Minimal | 6% NaOCl, 2% CHX, saline solution, and EDTA 17% or Ca(OH)2 and 2% CHX gel | TAP | 3 | NR | Resin bonded restoration |
| Jeeruphan et al., 2012 [ | Secondary to trauma/Caries | No | Minimal | 5.25% NaOCl | TAP | 3 | NR | NR |
| Silujjai et al., 2017 [ | Secondary to trauma/Caries/Dens evaginatus | Yes | No | 1.5–2.5% NaOCl followed by 17% EDTA | Ca(OH)2 or TAP | NR | NR | MTA plus bonded restoration |
| Chen et al., 2016 [ | Dens evaginatus | Yes | Minimal (#25 K file) | Copious 2.5% NaOCl | NR | NR | NR | NR |
Legend: APC = autologous platelet concentrate; NR = not reported; NaOCl = sodium hypochlorite; CHX = chlorhexidine; EDTA = ethylene diamine tetra-acetic acid; DAP = double antibiotic paste; TAP = triple antibiotic paste; Ca(OH)2 = calcium hydroxide; GI = glass ionomer; PRP = platelet-rich plasma; cPRP = concentrated platelet-rich plasma; PPP = platelet-poor plasma; PRF = platelet-rich fibrin; CEJ = cementoenamel junction; MTA = mineral trioxide aggregate; hDPSC = human dental pulp stem cells.
Figure 2Quality assessment of included RCT studies summary: review authors’ judgements about each risk of bias item for each included study.
Figure 3Quality assessment of included NRCT studies summary: review authors’ judgements about each risk of bias item for each included study.
Data extraction from included studies for qualitative analysis – clinical evaluation parameters.
| Author | Intervention | Type of Study | Comparative Group | Sample Size | Follow Up Time (in Months) | RA | Parameters to Assess Clinical Evaluation | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DWT | IRL | AFW | AC | VR | PAH | BD | |||||||
| Alagl et al., 2017 [ | REP | RCT | BC | 15 | 12 | CBCT | - | 11.80 ± | - | 53.33% | 53.33% | - | 445.44 ± 153.54 HU |
| PRP | 15 | - | 12.14 ± | - | 93.33% | 86.66% | - | 485.88 ± 154.15 HU | |||||
| Bezgin et al., 2015 [ | REP | RCT | BC | 10 | 18 | IOPAR | - | 12.6% | - | 60% | 20% | - | - |
| PRP | 10 | - | 9.86% | - | 70% | 50% | - | - | |||||
| Elsheshtawy et al., 2020 [ | REP | RCT | BC | 11 | 12 | CBCT | ICC = 1 | ICC = 0.998 | ICC = 1 | - | - | - | - |
| PRP | 11 | ICC = 0.997 | ICC = 0.999 | ICC = 0.998 | - | - | - | - | |||||
| Jadhav et al., 2012 [ | REP | RCT | BC | 10 | 12 | IOPAR | S = 70% | S = 40% | - | S = 50% | - | S = 30%, G = 70% | - |
| PRP | 10 | S = 20%, | S = 10% | - | G = 30%, E = 70% | - | S = 10% | - | |||||
| Rizk et al., 2019 [ | REP | RCT | BC | 13 | 12 | IOPAR | - | 0.68 ± 0.44 mm | 2.2 ± 3.97 mm | - | - | - | 58.96 ± 19.95 Grey |
| PRP | 13 | - | 1.48 ± 0.37 mm | 2.49 ± 3.93 mm | - | - | - | 65.08 ± 30.043 Grey | |||||
| Ragab et al., 2019 [ | REP | RCT | BC | 11 | 12 | IOPAR | - | 14.8% | - | 45.4% | - | 80.5% | - |
| PRF | 11 | - | 12.8% | - | 63.6% | - | 70.2% | - | |||||
| Mittal et al., 2019 [ | REP | RCT | BC | 4 | 12 | IOPAR | 100% | 25% | - | 25% | - | 75% | - |
| PRF | 4 | 100% | 0 | - | 100% | - | 75% | - | |||||
| Shivashankar et al., 2017 [ | REP | RCT | BC | 15 | 12 | IOPAR | 93.3% | 86.7% | - | - | 13.30% | 2.07 ± 0.594 mm | - |
| PRP | 19 | 84.2% | 73.7% | - | - | 15.8% | 1.32 ± 0.478 mm | - | |||||
| PRF | 20 | 70% | 65% | - | - | 15% | 1.85 ± 1.040 mm | - | |||||
| Hazim Rizk et al., 2020 [ | REP | RCT | PRP | 13 | 12 | IOPAR | - | 1.48 ± 0.37 mm | 0.97 ± 0.75 mm | - | - | - | 65.08 ± 30.043 Grey |
| PRF | 12 | - | 1.24 ± 0.54 mm | 1.003 ± 0.392 mm | - | - | - | 53.44 ± 22.165 Grey | |||||
| Jiang et al., 2017 [ | REP | RCT | Without Bio-Gide | 22 | 6 | IOPAR | 21.2 ± 19.5% | 15.4 ± 13.6% | −55 ± 34% | - | 18% | - | - |
| With Bio-Gide | 21 | 21.5 ± 22.5% | 16.4 ± 13.6% | −65 ± 34% | - | 33% | - | - | |||||
| Narang et al., 2015 [ | REP | RCT | MTA | 5 | 18 | IOPAR | 0% | 0% | - | 0% | - | 58% | - |
| BC | 5 | 50% | 40% | - | 66.67% | - | 60% | - | |||||
| PRP | 5 | 60% | 99% | - | 40% | - | 98% | - | |||||
| PRF | 5 | 20% | 40% | - | 60% | - | 80% | - | |||||
| Meschi et al., 2021 [ | REP | RCT | REP-LPRF | 13 | 36 | CBCT | 30% | 0% | - | - | - | 100% | - |
| REP + LPRF | 6 | 10% | 10% | - | - | - | 100% | - | |||||
| Ulusoy et al., 2019 [ | REP | RCT | BC | 21 | Until complete healing 10–49 | IOPAR | 14.91 ± 3.38 mm | 7.15 ±1.39 mm | - | - | - | - | - |
| PRP | 18 | 19.01 ± 4.20 mm | 4.74 ± 0.91 mm | - | - | - | - | - | |||||
| PRF | 17 | 9.80 ± 3.03 mm | 6.00 ± 1.57 mm | - | - | - | - | - | |||||
| PP | 17 | 8.55 ± 3.55 mm | 4.17 ± 1.33 mm | - | - | - | - | - | |||||
| Jayadevan et al., 2021 [ | REP | RCT | PRF | 10 | 12 | IOPAR | 50% | 80% | 45.5% | ||||
| APRF | 11 | 91% | 72% | 40% | |||||||||
| Peng et al., 2017 [ | REP | NRCT | Conventional GIC | 32 | 12 | IOPAR | 26.3% | 10.5% | - | - | - | - | - |
| ProRoot MTA | 28 | 30.7% | 11.0% | - | - | - | - | - | |||||
| Lv et al., 2018 [ | REP | NRCT | BC | 5 | 12 | IOPAR | 80% | 80% | - | 80% | 100% | 100% | - |
| PRF | 5 | 80% | 80% | - | 80% | 100% | 100% | - | |||||
| Cheng et al., 2022 [ | REP | NRCT | BC | 32 | 16 | IOPAR | F = 17.4 ± 16.4% | F = 8.3 ± 11.7% | F = 76.4 ± 30.9% | ||||
| CGF | 30 | ||||||||||||
| Chueh et al., 2009 [ | REP | NRCT | MTA | 8 | 6–108 | IOPAR | - | 87.5% | 87.5% | - | - | - | - |
| MTA + GP/GP/ | 15 | - | 93.33% | 80% | - | - | - | - | |||||
| Bonte et al., 2014 [ | APP | RCT | MTA | 15 | 12 | IOPAR | - | - | 76.5% | - | - | 82.4% | - |
| CH | 15 | - | - | 50% | - | - | 75.0% | - | |||||
| Santhakumar et al., 2018 [ | APP | RCT | PRF Gel | 19 | 18 | IOPAR | - | 94.73% | - | - | 100% | - | - |
| PRF Membrane | 19 | - | 89.47% | - | - | 100% | - | - | |||||
| Kandemir Demirci et al., 2019 [ | APP | NRCT | MTA | 39 | 12 | IOPAR | - | - | 74% | - | - | 92% | - |
| CH | 34 | - | - | 79% | - | - | 91% | - | |||||
| Tek et al., 2021 [ | APP | NRCT | Apical plug with MTA | 10 | 12 | IOPAR | - | - | - | - | - | 50% | - |
| Collagen sponge + apical plug with MTA | 10 | - | - | - | - | - | 62.5% | - | |||||
| Kinirons et al., 2001 [ | APP | NRCT | CH in Newcastle | 43 | 3 | IOPAR | - | - | 100% | - | - | - | - |
| CH in Belfast | 64 | - | - | 100% | - | - | - | - | |||||
| Lin et al., 2017 [ | REP vs. APP | RCT | BC | 69 | 12 | CBCT | 82.60% | 81.16% | - | 65.21% | - | 100% | - |
| Vitapex paste | 34 | 0% | 26.47% | - | 82.35% | - | 100% | - | |||||
| Xuan et al., 2018 [ | REP vs. APP | RCT | hDPSC | 20 | 12 | CBCT | - | 5.24 ± 0.92 mm | 2.64 ± 0.73 mm | - | 43.43 ± 0.86 mm | - | - |
| CH | 10 | - | 0.88 ± 0.67 mm | 0.62 ± 0.22 mm | - | 0.17 ± 0.16 mm | - | - | |||||
| Alobaid et al., 2014 [ | REP vs. APP | NRCT | BC | 19 | 15–22 | IOPAR | - | 20% | 10.2 ± −4.0% | - | - | - | - |
| CH & MTA | 12 | - | 12.5% | 1.4 ± −3.2% | - | - | - | - | |||||
| Casey et al., 2022 [ | REP vs. APP | NRCT | BC | 93 | 31–33 | IOPAR | - | - | - | - | 19% | - | - |
| CH & MTA | 118 | - | - | - | - | 0 | - | - | |||||
| Caleza-Jimenez et al., 2022 [ | REP vs. APP | NRCT | BC | 9 | 6–66 | IOPAR | 12.76% | 34.57 ± | |||||
| MTA | 9 | 0.29% | −3.36 ± 4.13% | ||||||||||
| Pereira et al., 2021 [ | REP vs. APP | NRCT | BC | 22 | 12–30 | IOPAR | 0.21 ± 0.35 mm | 1.42 ± 1.25 mm | 0.88 ± 0.77 mm | - | - | 95.45% | - |
| MTA | 22 | 0.03 ± 0.07 mm | 0.88 ± 0.7 mm | 0.6 ± 0.51 mm | - | - | 86.36% | - | |||||
| Jeeruphan et al., 2012 [ | REP vs. APP | NRCT | BC | 20 | 24 | IOPAR | - | 14.9% | 28.2% | - | - | 80% | - |
| MTA | 19 | - | 6.1% | 0.00% | - | - | 68% | - | |||||
| CH | 22 | - | 0.4% | 1.52% | - | - | 77% | - | |||||
| Silujjai et al., 2017 [ | REP vs. APP | NRCT | BC | 17 | 12–96 | IOPAR | - | 9.51 ± 18.14% | 13.75 ± 19.91% | - | - | - | - |
| MTA | 26 | - | 8.55 ± 8.97% | −3.30 ± 14.14% | - | - | - | - | |||||
| Chen et al., 2016 [ | REP vs. APP | NRCT | CH, BC, MTA | 17 | 12 | IOPAR | - | 94.12% | - | - | - | - | - |
| CH, MTA | 21 | - | 85.71% | - | - | - | - | - | |||||
Legend: REP = Regenerative Endodontic Procedure; APP = Apexification Procedure; RCT = Randomized clinical trial; NRCT = Non-randomised clinical trial; DWT = Dentin wall thickness; IRL = Increase in root length; AFW = Apical foramen width; AC = apical closure; VR = Vitality response; PAH = Periapical healing; BD = Bone density; BC = Blood clot; PRP = Platelet rich plasma; PRF = Platelet rich fibrin; PP = Platelet plug; MTA = Mineral trioxide aggregate; CH = Calcium hydroxide; hDPSC = Human dental pulp stem cells; RA = radiological assessment; IOPAR = Intraoral periapical radiographs; CBCT = cone-beam computed tomography; S = Satisfactory; G= Good; E= Excellent; ICC= Intraclass Correlation Coefficient; HU= Hounsfield units F= Fracture; L = Luxation; Ci= Combined injuries; A= Avulsion.
Figure 4Meta-analysis of dentin wall thickness (DWT) in regenerative endodontic procedure (REP) using APC or BC.
Figure 5Meta-analysis of increased root length (IRL) in regenerative endodontic procedure (REP) using APC or BC.
Figure 6Meta-analysis of apical foramen width (AFW) in regenerative endodontic procedure (REP) using APC or BC.
Figure 7Meta-analysis of vitality response (VR) in regenerative endodontic procedure (REP) using APC or BC.
Figure 8Meta-analysis of success rate in regenerative endodontic procedure (REP) using APC or BC.
Figure 9Meta-analysis of survival rate of young immature permanent teeth that underwent regenerative endodontic procedure (REP) or apexification procedure.
Figure 10Funnel plot showing publication bias of studies on survival rate of young immature permanent teeth that underwent regenerative endodontic procedure (REP) or apexification procedure.
Figure 11Meta-analysis of success rate in young immature permanent teeth undergoing regenerative endodontic procedure (REP) or apexification procedure.
Figure 12Funnel plot showing publication bias of studies on success rate in young immature permanent teeth undergoing regenerative endodontic procedure (REP) or apexification procedure.
Figure 13Meta-analysis of increase in root length (IRL) in young immature teeth treated with regenerative endodontic procedure (REP) or apexification procedure.
Figure 14Meta-analysis of apical foramen width (AFW) in young immature teeth treated with regenerative endodontic procedure (REP) or apexification procedure.